iTeos Therapeutics Inc. (ITOS)
NASDAQ: ITOS
· Real-Time Price · USD
10.10
-0.01 (-0.10%)
At close: Jun 24, 2025, 3:59 PM
10.09
-0.05%
After-hours: Jun 24, 2025, 04:38 PM EDT
-0.10% (1D)
| Bid | 9.91 |
| Market Cap | 386.37M |
| Revenue (ttm) | 35M |
| Net Income (ttm) | -130.81M |
| EPS (ttm) | -3.05 |
| PE Ratio (ttm) | -3.31 |
| Forward PE | -6.44 |
| Analyst | Hold |
| Ask | 10.17 |
| Volume | 556,412 |
| Avg. Volume (20D) | 1,301,320 |
| Open | 10.11 |
| Previous Close | 10.11 |
| Day's Range | 10.05 - 10.20 |
| 52-Week Range | 4.80 - 18.13 |
| Beta | 1.51 |
About ITOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ITOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ITOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 weeks ago
+17.94%
ITeos Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+13.44%
ITeos Therapeutics shares are trading higher after the company reported topline interim results from its GALAXIES Lung-201 study of Belrestotug + Dostarlimab.
